CA2305312A1 - Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale - Google Patents

Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale Download PDF

Info

Publication number
CA2305312A1
CA2305312A1 CA002305312A CA2305312A CA2305312A1 CA 2305312 A1 CA2305312 A1 CA 2305312A1 CA 002305312 A CA002305312 A CA 002305312A CA 2305312 A CA2305312 A CA 2305312A CA 2305312 A1 CA2305312 A1 CA 2305312A1
Authority
CA
Canada
Prior art keywords
seq
nucleic acid
gene product
gene
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002305312A
Other languages
English (en)
Other versions
CA2305312C (fr
Inventor
Donald H. Rubin
Edward L. Organ
Raymond N. Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2696653A priority Critical patent/CA2696653A1/fr
Publication of CA2305312A1 publication Critical patent/CA2305312A1/fr
Application granted granted Critical
Publication of CA2305312C publication Critical patent/CA2305312C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA2305312A 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale Expired - Fee Related CA2305312C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2696653A CA2696653A1 (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6202197P 1997-10-10 1997-10-10
US60/062,021 1997-10-10
PCT/US1998/021276 WO1999019481A2 (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2696653A Division CA2696653A1 (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale

Publications (2)

Publication Number Publication Date
CA2305312A1 true CA2305312A1 (fr) 1999-04-22
CA2305312C CA2305312C (fr) 2010-03-23

Family

ID=22039706

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2305312A Expired - Fee Related CA2305312C (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale
CA2696653A Abandoned CA2696653A1 (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2696653A Abandoned CA2696653A1 (fr) 1997-10-10 1998-10-08 Genes mammaliens intervenant dans l'infection virale et la neutralisation tumorale

Country Status (5)

Country Link
EP (1) EP1021536A2 (fr)
JP (2) JP2001520012A (fr)
AU (1) AU9604198A (fr)
CA (2) CA2305312C (fr)
WO (1) WO1999019481A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016323A2 (fr) * 1999-09-01 2001-03-08 Subsidiary N0.3, Inc. Compositions et procedes d'inhibition de l'infection due au virus de l'immunodeficience humaine a l'aide de genes cellulaires humains a regulation negative
JP2002300900A (ja) * 2001-04-05 2002-10-15 National Institute Of Advanced Industrial & Technology 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法
US20030087273A1 (en) * 2001-06-29 2003-05-08 Holzmayer Tanya A. Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
US7691599B2 (en) 2002-05-02 2010-04-06 Zirus, Inc. Mammalian genes involved in viral infection and tumor suppression
EP2339009A1 (fr) * 2009-12-22 2011-06-29 Sandoz Ag Séquences promotrices inductibles à froid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2046607C (fr) * 1989-02-14 2002-04-16 Rima Kaddurah-Daouk Inhibition de la transformation de cellules presentant un metabolisme des purines eleve
US5364783A (en) * 1990-05-14 1994-11-15 Massachusetts Institute Of Technology Retrovirus promoter-trap vectors
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
WO1997039119A1 (fr) * 1996-04-15 1997-10-23 Vanderbilt University Genes mammiferes impliques dans l'infection virale et la suppression de tumeurs

Also Published As

Publication number Publication date
JP2001520012A (ja) 2001-10-30
WO1999019481A2 (fr) 1999-04-22
CA2305312C (fr) 2010-03-23
AU9604198A (en) 1999-05-03
JP2009100780A (ja) 2009-05-14
CA2696653A1 (fr) 1999-04-22
WO1999019481A3 (fr) 1999-11-04
EP1021536A2 (fr) 2000-07-26

Similar Documents

Publication Publication Date Title
Takenaga et al. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells
Noda et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
MacGrogan et al. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22
CA2234071C (fr) Promoteur homologue puissant obtenu a partir de hamsters
Li et al. A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed
Tiranti et al. Chromosomal localization of mitochondrial transcription factor A (TCF6), single-stranded DNA-binding protein (SSBP), and endonuclease G (ENDOG), three human housekeeping genes involved in mitochondrial biogenesis
Ma et al. Identification of a homeobox-containing gene with enhanced expression during soybean (Glycine max L.) somatic embryo development
Katsanis et al. A Novel C-Terminal Binding Protein (CTBP2) Is Closely Related toCTBP1, an Adenovirus E1A-Binding Protein, and Maps to Human Chromosome 21q21. 3
Kim et al. cDNA cloning and characterization of buforin I, an antimicrobial peptide: a cleavage product of histone H2A
Fakharzadeh et al. Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene
Arima et al. A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC
Stoler et al. Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells
JP2006507807A5 (fr)
Ferrari et al. The gene encoding human vimentin is located on the short arm of chromosome 10
Powell et al. Clustered arrangement of keratin intermediate filament genes.
Tulchinsky et al. Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation
Nehlin et al. Genomic organization, sequence, and chromosomal localization of the human helix–loop–helix Id1 gene
Tarantul et al. Differential gene expression in B-cell non-Hodgkin's lymphoma of SIV-infected monkey
Chansky et al. Expression of cartilage extracellular matrix and potential regulatory genes in a new human chondrosarcoma cell line
Pomykala et al. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines
Rowe et al. Transformation of rodent cells by DNA extracted from transformation-defective adenovirus mutants
Seiser et al. Mouse thymidine kinase: the promoter sequence and the gene and pseudogene structures in normal cells and in thymidine kinase deficient mutants
Lin et al. Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island
Kemler et al. Characterization of two nonallelic pairs of late histone H2A and H2B genes of the sea urchin: differential regulation in the embryo and tissue-specific expression in the adult
JP2001520012A5 (fr)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131009